This Weekly’s Hot Topics
- No-cost technical assistance on MACRA for California physicians. (California News)
- FDA Reauthorization Act of 2017 signed into (National News)
- DHHS has delayed the 340B final rule (CMS News)
The price disclosure bill, SB 17 by state Sen. Ed Hernandez (D-Azusa), is now one of five measures, in Sacramento, that have been proposed to tackle prescription costs. The California Cancer PAC is “watching” this bill as it goes through various iterations. For more information click here and go to California News.
The Health Services Advisory Group, in partnership with the California Health Information Partnership & Services Organization, is providing no-cost technical assistance to physician offices in California to help them prepare for and participate in the Quality Payment Program, established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). For more information click here and go to California News.
This Friday, August 25th, the Department of Managed Health Care (DMHC) invites you to a public meeting on the development of the standard formulary template as required by Senate Bill 1052 (2015). The meeting will be held at 980 9th Street, 5th Floor, Sacramento, 95814, beginning at 10:00 a.m. and ending after the last public comment is received. Seating is limited for in-person attendance and will be on a first-come, first-served basis. For more information click here and go to DMHC News.
The need to have end-of-life planning conversations with your critically ill patients, taking a half hour or more for those talks is covered by Medicare. CMS finalized the creation of the new codes in the 2016 physician fee schedule and allowed clinicians to bill Medicare for those conversations. The CMS rates range from $80 to $86 for the first 30 minutes and about $75 for each additional 30 minutes. The creation of this new billing code has been an important catalyst for ensuring that providers, Medicare beneficiaries and their families all know the patient’s desired care for his or her final days and preventing unwanted, intensive medical interventions from being performed. For more information click here and go to CMS News.
NCCN has published and/or updated their Chemotherapy Order Templates; Clinical Practice Guidelines in Oncology, Drugs & Biologics Compendium; Evidence Blocks; Guidelines for Patients; Imaging Appropriate Use Criteria; and/or, Radiation Therapy Compendium for hepatobiliary cancers (V3.2017); Smoking Cessation (V2.2017). NCCN published the following correction to the NCCN Chemotherapy Order Templates (NCCN Templates®): A dosing error that would lead to underdosing of methotrexate was found on the following chemotherapy order template. For more information click here and go to Affiliate Association News.
To view the complete California Oncology Weekly Newsletter, click on the date below.
August 22, 2017